Preterm

Jury Considers Record $6 Billion Payout in Major Preterm Infant Formula Lawsuit Against Abbott, Reckitt’s Mead

by

In a significant legal escalation, attorneys representing numerous families impacted by alleged defective preterm infant formula are seeking damages exceeding $6 billion from health care company Abbott Laboratories and consumer goods manufacturer Reckitt. The lawsuit underlines grave concerns over the safety and consequences of the infant formula products these families have trusted. The case, spotlighting two major brands, Abbott’s Similac and Reckitt’s Enfamil, claims these products contributed adversely to the health of newborns, necessitating comprehensive medical attention and extended hospital stays. Representatives for the families contend that these formulas, specifically marketed for premature infants, have … Read more

Jury Deliberates Multibillion-Dollar Claim in Landmark Preterm Infant Formula Lawsuit Against Top Manufacturers

by

A jury in Wilmington, Delaware, is currently deliberating over a substantial lawsuit in which families are seeking over $6 billion from Abbott Laboratories and Reckitt Benckiser’s Mead Johnson. The lawsuit alleges that the companies failed to provide adequate warnings about the potential risks associated with consuming their cow’s milk-based infant formula for premature babies. The legal dispute centers around claims that ingesting these formulas can lead to a serious gastrointestinal disease known as necrotizing enterocolitis (NEC), which particularly affects preterm or otherwise medically vulnerable infants. NEC can cause severe intestinal damage and is potentially lethal. … Read more